Cas:15571-58-1 2-ethylhexyl 2-[[2-(2-ethylhexoxy)-2-oxoethyl]sulfanyl-dioctylstannyl]sulfanylacetate manufacturer & supplier

Chemical Name:2-ethylhexyl 2-[[2-(2-ethylhexoxy)-2-oxoethyl]sulfanyl-dioctylstannyl]sulfanylacetate

CAS.NO:15571-58-1

Synonyms:Advastab 17MOL;Advastab 17 mok;2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate;Di-n-octyltin-2-ethylhexyl-dimercaptoethanoate;EINECS 239-622-4;17MOK;KS 2000A10

Molecular Formula:C₃₆H₇₂O₄S₂Sn

Molecular Weight:751.78500

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:103.20000

Exact Mass:752.38900

LogP:12.13520

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:UN 2788

Packing Group:III

Contact us for information like Advastab 17MOL chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,KS 2000A10 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Advastab 17MOL Use and application,Di-n-octyltin-2-ethylhexyl-dimercaptoethanoate technical grade,usp/ep/jp grade.

Related News: With the continuous advancement of economic globalization, the division of labor and cooperation around the world has become increasingly apparent. The fine chemical industry has the foundation of global division of labor and cooperation due to its long and complex industrial chain. 2-ethylhexyl 2-[[2-(2-ethylhexoxy)-2-oxoethyl]sulfanyl-dioctylstannyl]sulfanylacetate manufacturer The FDA has granted so-called accelerated approval in more than 250 instances since 1992, mainly for rare diseases or small patient populations that have had no effective treatments available to them. In these cases, the agency requires that drugmakers conduct additional clinical trials to prove their therapy works, or face withdrawal from the market. 2-ethylhexyl 2-[[2-(2-ethylhexoxy)-2-oxoethyl]sulfanyl-dioctylstannyl]sulfanylacetate supplier The FDA has granted so-called accelerated approval in more than 250 instances since 1992, mainly for rare diseases or small patient populations that have had no effective treatments available to them. In these cases, the agency requires that drugmakers conduct additional clinical trials to prove their therapy works, or face withdrawal from the market. 2-ethylhexyl 2-[[2-(2-ethylhexoxy)-2-oxoethyl]sulfanyl-dioctylstannyl]sulfanylacetate vendor With the continuous advancement of economic globalization, the division of labor and cooperation around the world has become increasingly apparent. The fine chemical industry has the foundation of global division of labor and cooperation due to its long and complex industrial chain. 2-ethylhexyl 2-[[2-(2-ethylhexoxy)-2-oxoethyl]sulfanyl-dioctylstannyl]sulfanylacetate factory A number of UK citizens had trouble reaching the muster point in time for the first flight out because of road blocks and other restrictions in place in Wuhan.